Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor

K. W. Peng, P. D. Holler, B. A. Orr, David M Kranz, S. J. Russell

Research output: Contribution to journalArticle

Abstract

The T-cell receptor (TCR) determines the specificity of T-cell recognition by binding to peptide fragments of intracellular proteins presented at the cell surface in association with molecules of the major histocompatibility complex (MHC). Engagement of the TCR by its cognate peptide/MHC ligand, with appropriate co-stimulatory signals, leads to activation of T-cell effector functions. Here we show that the attachment proteins of attenuated measles viruses, engineered to display a high-affinity single-chain TCR (scTCR), can recognize and bind to specific peptide-MHC complexes and thereby mediate targeted virus-cell entry and cell-to-cell fusion. Using the 2C TCR and its peptide/MHC ligand (SIYRYYGL/mouse Kb), we show that a scTCR grafted onto the measles virus H protein confers new specificity to virus entry and cell fusion. The efficiency of TCR-mediated virus entry was dependent on the number of peptide/MHC complexes expressed on the target cells, increasing progressively above densities higher than 2500 complexes per cell. This work introduces a new paradigm for targeting virus entry and membrane fusion by extending the repertoire of targets to specific peptide-MHC ligands and offering a novel quantitative readout for the cellular expression of peptide-MHC complexes.

Original languageEnglish (US)
Pages (from-to)1234-1239
Number of pages6
JournalGene therapy
Volume11
Issue number15
DOIs
StatePublished - Aug 1 2004

Fingerprint

Virus Internalization
T-Cell Antigen Receptor
Major Histocompatibility Complex
Peptides
Cell Fusion
Ligands
T-Cell Antigen Receptor Specificity
T-Lymphocytes
Measles virus
Peptide Fragments
Proteins

Keywords

  • Measles virus
  • Peptide/MHC complexes
  • Single-chain TCR
  • Targeting

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor. / Peng, K. W.; Holler, P. D.; Orr, B. A.; Kranz, David M; Russell, S. J.

In: Gene therapy, Vol. 11, No. 15, 01.08.2004, p. 1234-1239.

Research output: Contribution to journalArticle

Peng, K. W. ; Holler, P. D. ; Orr, B. A. ; Kranz, David M ; Russell, S. J. / Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor. In: Gene therapy. 2004 ; Vol. 11, No. 15. pp. 1234-1239.
@article{4045393e00a8493896466fa802bfddee,
title = "Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor",
abstract = "The T-cell receptor (TCR) determines the specificity of T-cell recognition by binding to peptide fragments of intracellular proteins presented at the cell surface in association with molecules of the major histocompatibility complex (MHC). Engagement of the TCR by its cognate peptide/MHC ligand, with appropriate co-stimulatory signals, leads to activation of T-cell effector functions. Here we show that the attachment proteins of attenuated measles viruses, engineered to display a high-affinity single-chain TCR (scTCR), can recognize and bind to specific peptide-MHC complexes and thereby mediate targeted virus-cell entry and cell-to-cell fusion. Using the 2C TCR and its peptide/MHC ligand (SIYRYYGL/mouse Kb), we show that a scTCR grafted onto the measles virus H protein confers new specificity to virus entry and cell fusion. The efficiency of TCR-mediated virus entry was dependent on the number of peptide/MHC complexes expressed on the target cells, increasing progressively above densities higher than 2500 complexes per cell. This work introduces a new paradigm for targeting virus entry and membrane fusion by extending the repertoire of targets to specific peptide-MHC ligands and offering a novel quantitative readout for the cellular expression of peptide-MHC complexes.",
keywords = "Measles virus, Peptide/MHC complexes, Single-chain TCR, Targeting",
author = "Peng, {K. W.} and Holler, {P. D.} and Orr, {B. A.} and Kranz, {David M} and Russell, {S. J.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1038/sj.gt.3302286",
language = "English (US)",
volume = "11",
pages = "1234--1239",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "15",

}

TY - JOUR

T1 - Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor

AU - Peng, K. W.

AU - Holler, P. D.

AU - Orr, B. A.

AU - Kranz, David M

AU - Russell, S. J.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - The T-cell receptor (TCR) determines the specificity of T-cell recognition by binding to peptide fragments of intracellular proteins presented at the cell surface in association with molecules of the major histocompatibility complex (MHC). Engagement of the TCR by its cognate peptide/MHC ligand, with appropriate co-stimulatory signals, leads to activation of T-cell effector functions. Here we show that the attachment proteins of attenuated measles viruses, engineered to display a high-affinity single-chain TCR (scTCR), can recognize and bind to specific peptide-MHC complexes and thereby mediate targeted virus-cell entry and cell-to-cell fusion. Using the 2C TCR and its peptide/MHC ligand (SIYRYYGL/mouse Kb), we show that a scTCR grafted onto the measles virus H protein confers new specificity to virus entry and cell fusion. The efficiency of TCR-mediated virus entry was dependent on the number of peptide/MHC complexes expressed on the target cells, increasing progressively above densities higher than 2500 complexes per cell. This work introduces a new paradigm for targeting virus entry and membrane fusion by extending the repertoire of targets to specific peptide-MHC ligands and offering a novel quantitative readout for the cellular expression of peptide-MHC complexes.

AB - The T-cell receptor (TCR) determines the specificity of T-cell recognition by binding to peptide fragments of intracellular proteins presented at the cell surface in association with molecules of the major histocompatibility complex (MHC). Engagement of the TCR by its cognate peptide/MHC ligand, with appropriate co-stimulatory signals, leads to activation of T-cell effector functions. Here we show that the attachment proteins of attenuated measles viruses, engineered to display a high-affinity single-chain TCR (scTCR), can recognize and bind to specific peptide-MHC complexes and thereby mediate targeted virus-cell entry and cell-to-cell fusion. Using the 2C TCR and its peptide/MHC ligand (SIYRYYGL/mouse Kb), we show that a scTCR grafted onto the measles virus H protein confers new specificity to virus entry and cell fusion. The efficiency of TCR-mediated virus entry was dependent on the number of peptide/MHC complexes expressed on the target cells, increasing progressively above densities higher than 2500 complexes per cell. This work introduces a new paradigm for targeting virus entry and membrane fusion by extending the repertoire of targets to specific peptide-MHC ligands and offering a novel quantitative readout for the cellular expression of peptide-MHC complexes.

KW - Measles virus

KW - Peptide/MHC complexes

KW - Single-chain TCR

KW - Targeting

UR - http://www.scopus.com/inward/record.url?scp=4243139564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4243139564&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3302286

DO - 10.1038/sj.gt.3302286

M3 - Article

C2 - 15215883

AN - SCOPUS:4243139564

VL - 11

SP - 1234

EP - 1239

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 15

ER -